Cell and molecular biology of gastrointestinal tract cancer

Curr Opin Oncol. 1992 Aug;4(4):707-13. doi: 10.1097/00001622-199208000-00017.

Abstract

The gene for familial adenomatous polyposis coli (APC or FAP), which has previously been linked to chromosome 5q21 has been identified. The APC gene has been found to be altered by point mutations in the germ line of both adenomatous polyposis coli and Gardner's syndrome patients and somatically in tumors from sporadic colorectal cancer patients. During the hunt for the APC gene, the closely linked MCC (mutated in colorectal cancer) gene was identified and found to be altered somatically in tumors from sporadic cancer patients. These data suggest that more than one gene on chromosome 5q21 may contribute to colorectal carcinogenesis and that mutations at the APC gene can cause both adenomatous polyposis coli and Gardner's syndrome. The identification of these genes should aid in the counseling of patients with genetic predispositions to colorectal cancer. Progress has also been made in identifying specific genetic changes that occur in other gastrointestinal cancers. A mutational "hotspot" in the p53 gene in human hepatocellular carcinomas has been identified that could reflect exposure to a specific carcinogen, one candidate being aflatoxin B1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenomatous Polyposis Coli / genetics
  • Animals
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Chromosome Aberrations
  • Chromosome Deletion
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Diet
  • Gardner Syndrome / genetics
  • Gastrointestinal Neoplasms / genetics
  • Gastrointestinal Neoplasms / pathology*
  • Genes, Tumor Suppressor
  • Genes, p53
  • Genetic Predisposition to Disease
  • Humans
  • Oncogenes
  • Rats
  • Transforming Growth Factor beta / physiology

Substances

  • Biomarkers, Tumor
  • Transforming Growth Factor beta